Articles

Podcasts

Videos

Youth with repeat concussion have worse outcomes and more delays returning to normal life.

Majority of Youth Fully Recover 1 Year Post-Concussion

Approximately 50% of patients with a mTBI who experience fatigue or sleep-wake disturbances 2 weeks following the injury continue to have problems at the 3 month mark.

Traumatic Brain Injuries Linked to Sleep, Fatigue Problems

Considerable discrepancy found between overt clinical symptoms of laryngeal pathology and abnormalities observed during a task protocol.

Laryngeal Movement Disorders Distinguish MSA from Parkinson Disease

Satralizumab represents only the second targeted treatment for NMOSD and the first cleared for at-home administration.

FDA Approves New Neuromyelitis Optica Spectrum Disorder Treatment

The approval is based on findings from a phase 2 clinical trial.

FDA Approves Viltolarsen for Duchenne Muscular Dystrophy

A team of researchers have added 3 new modifiable risk factors to a list of 9 known factors that increase the risk of developing dementia.

Naahaad Mukadam, PhD: Addressing the Dementia Public Health Crisis

Investigators found a 22% reduction in clinical decline at the 78-week cutoff in the intent to treat population in EMERGE who received high-dose aducanumab, with a similar reduction seen in the opportunity to complete population. 

FDA Sets PDUFA Date on Aducanumab for Alzheimer Disease

In a pair of studies, 42% of patients and care partners reported having no current treatment.

 Dementia-Related Psychosis a Burden for Both Patients and Caretakers

Approximately 5% of the 13,000 TBI patients examined died during the course of the study.

High Variability Found in Mortality from Traumatic Brain Injuries

The FDA approved the CBD solution following the results of a randomized, double-blind, placebo-controlled trial.

Neurology